RaySearch Laboratories AB (publ) RSLBF
20.00 USD 0.00 (+0.00%)
Regular-session close
16.85 Day range 16.85
16.49 52-week range 27.61
- YTD
- -15.97%
- 1 year
- -27.56%
News
seekingalpha.com RaySearch Laboratories AB (publ) (RSLBF) Q3 2026 Earnings Call Transcript RaySearch Laboratories AB (publ) (RSLBF) Q3 2026 Earnings Call Transcript
seekingalpha.com RaySearch Laboratories AB (publ) (RSLBF) Q2 2026 Earnings Call Transcript RaySearch Laboratories AB (publ) (RSLBF) Q2 2026 Earnings Call Transcript
seekingalpha.com RaySearch Laboratories AB (publ) (RSLBF) Q1 2026 Earnings Call Transcript RaySearch Laboratories AB (publ) (RSLBF) Q1 2026 Earnings Call Transcript
seekingalpha.com RaySearch Laboratories AB (publ) (RSLBF) Q4 2025 Earnings Call Transcript RaySearch Laboratories AB (publ) (RSLBF) Q4 2025 Earnings Call Transcript
seekingalpha.com RaySearch Laboratories AB (publ) (RSLBF) Q3 2025 Earnings Call Transcript RaySearch Laboratories AB (publ) (OTCPK:RSLBF) Q3 2025 Earnings Call November 7, 2025 4:00 AM EST Company Participants Carolina Stromlid - Head of Investor Relations Johan Löf - Founder, CEO,…
prnewswire.com RaySearch Laboratories: Interim report April - June 2025 STOCKHOLM , Aug. 8, 2025 /PRNewswire/ -- SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3) Net sales amounted to SEK 304.9 (318.9) Operating profit amounted to SEK 36.4…
prnewswire.com Interim report January 1 - March 31, 2025: RaySearch Laboratories STOCKHOLM , May 9, 2025 /PRNewswire/ -- FIRST QUARTER (JANUARY - MARCH 2025) Order intake amounted to SEK 409.6 M (238.5) Net sales amounted to SEK 331.7 M (257.2) Operating profit amounted to SEK…
prnewswire.com RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO STOCKHOLM , May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full…
prnewswire.com Completed placing of shares in RaySearch Laboratories AB (publ) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION…
prnewswire.com Contemplated placement of existing shares in RaySearch Laboratories AB NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION…
prnewswire.com RaySearch Laboratories: Year-end report 2024 STOCKHOLM , Feb. 21, 2025 /PRNewswire/ -- FOURTH QUARTER (OCTOBER - DECEMBER 2024) Order intake SEK 305.0 M (317.7) Net sales SEK 322.7 (299.6) Operating profit SEK 73.6 M (44.4) Profit after tax SEK…
prnewswire.com RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024 STOCKHOLM , Nov. 29, 2024 /PRNewswire/ -- RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the largest conference show in the field…
prnewswire.com RaySearch Laboratories: Interim report July - September 2024 STOCKHOLM , Nov. 8, 2024 /PRNewswire/ -- THIRD QUARTER (JULY - SEPTEMBER 2024) Order intake SEK 253.4 M (240.7) Net sales SEK 293.3 (252.9) Operating profit SEK 61.8 M (28,6) Profit after tax SEK…
prnewswire.com RaySearch Laboratories: Interim report April - June 2024 STOCKHOLM , Aug. 16, 2024 /PRNewswire/ -- SECOND QUARTER (APRIL- JUNE 2024) Order intake SEK 290.3 M (239.2) Net sales SEK 318.9 M (239.5) Operating profit SEK 79.3 M (18.2) Profit after tax SEK 61.4…
prnewswire.com RaySearch Laboratories: Interim report January 1 - March 31, 2024 STOCKHOLM , May 17, 2024 /PRNewswire/ -- FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6) Net sales SEK 257.2 M (230.2) Operating profit SEK 45.8 M (23.7) Profit after tax SEK…
prnewswire.com RaySearch Laboratories: Year-end report 2023 STOCKHOLM , Feb. 23, 2024 /PRNewswire/ -- FOURTH QUARTER (OCTOBER - DECEMBER 2023) Order intake SEK 317.7 M (514.4) Net sales SEK 299.6 M (264.4) Operating profit SEK 44.4 M (20.7) Profit after tax…
prnewswire.com RaySearch Laboratories: Interim report January 1 - September 30, 2023 STOCKHOLM , Nov. 17, 2023 /PRNewswire/ -- THIRD QUARTER (JULY - SEPTEMBER 2023) Order intake SEK 240.7 M (219.1) Net sales SEK 252.9 M (210.9) Operating profit SEK 28.6 M (12.0) Profit after tax SEK…
prnewswire.com Invitation to presentation of RaySearch's interim report for the third quarter of 2023 STOCKHOLM , Oct. 30, 2023 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the third quarter of 2023 on November 17, 2023, at 10.00…
prnewswire.com RaySearch Laboratories : Interim report January 1 - June 30, 2023 STOCKHOLM , Aug. 25, 2023 /PRNewswire/ -- SECOND QUARTER (APRIL-JUNE 2023) Order intake SEK 239.2 M (212.5) Net sales SEK 239.5 M (160.2) Operating profit SEK 18.2 M (-19.5) Profit after tax SEK 10.9…
prnewswire.com Invitation to presentation of RaySearch's interim report for the second quarter of 2023 STOCKHOLM , Aug. 8, 2023 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the second quarter of 2023 on August 25, 2023, at 10.00 am…
